$0.00010
At close: May 2, 2:13 PM EDT
Comments
Loading...
Entia Biosciences Analyst Ratings and Price Targets | OTC:ERGO | Benzinga
Entia Biosciences Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Entia Biosciences Corp from these most-recent analyst ratings.
Analyst Ratings for Entia Biosciences
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Entia Biosciences (ERGO) stock?
There is no price target for Entia Biosciences
What is the most recent analyst rating for Entia Biosciences (ERGO)?
There is no analyst for Entia Biosciences
When was the last upgrade for Entia Biosciences (ERGO)?
There is no last upgrade for Entia Biosciences
When was the last downgrade for Entia Biosciences (ERGO)?
There is no last downgrade for Entia Biosciences.
When is the next analyst rating going to be posted or updated for Entia Biosciences (ERGO)?
There is no next analyst rating for Entia Biosciences.
Is the Analyst Rating Entia Biosciences (ERGO) correct?
There is no next analyst rating for Entia Biosciences.
Browse analyst ratings and price targets on all stocks.
